Want to learn more about the Hematology-Oncology Fellowship Program @WUHemeOncFellow at Test Account? See our video below. @WashUHeme Sana Saif Ur Rehman @NehaMehtaShahMD Stephen Oh @WUDeptMedicine Abby Spencer, MD, MS, FACP #MedEd Hem-Onc Fellows Network m.youtube.com/watch?v=M6ehgH…

**HIV Hodgkin therapy ✅Brentuximab vedotin–AVD was highly active and had a tolerable adverse event rate in HIV-cHL ✅The complete reponse rate is encouraging From Lee Ratner @WashUOnc and colleagues #nhlsm #lymsm @WUDeptMedicine Test Account Siteman Cancer Center thelancet.com/journals/lanha…

📣Saturday, September  2  @ 4 PM EST on MedNewsWeek!🎙️ We are excited to be hosting Global Leader & Keynote Speaker, 🌟Dr. Kathryn Lurain🌟– Clinical Director, HIV and AIDS Malignancy Branch at the NCI– as she discusses the latest in HIV 🦠 associated cancers 🦀.

NEW on our blog from guest contributor Beryne Odeny MD MPH PhD and Exec Ed Julia Robinson: Redefining the Practice of Global Health: Insights from the Consortium of Universities for Global Health (CUGH) 2023 conference speakingofmedicine.plos.org/2023/09/19/red…

In Blood Advances Rasmussen et al. highlight differences in progression free survival in KSHV/HHV8 associated multicentric Castleman disease by HIV status - despite uniform treatment, risk of progression is higher in HIV neg patients as compared with PWH. ashpublications.org/bloodadvances/…

Thomas Uldrick, MD and I explore these findings further in our editorial #HIVOnc ashpublications.org/bloodadvances/…

Reviving my account to express immense gratitude to the Winn Awards for the opportunity to join the Robert A Winn Diversity in Clinical Trials program - wrapping up the week I am reenergized and so thankful for the connection with new mentors, friends, and collaborators 😊😊😊

Honored to be part of the Winn CDA program, dedicated to promoting diversity in cancer clinical trials. 🌍 #WinnCDA #ClinicalTrials #DiversityinResearch #HIVOnc #GlobalOncology @WashUOnc KESHO

Gilead is proud to be a funding partner of The Robert A. Winn Diversity in Clinical Trials Award Program, designed to train early-stage investigator physicians and address the longstanding lack of diversity in clinical trials. Learn more: gilead.inc/3uHKj9h

Delighted that our paper on impact of bintrafusp alfa in NSCLC is out. Have some very long ongoing CR which limited our ability for post biopsies. Check it out 👉 jitc.bmj.com/content/12/3/e…

Only a couple of hours left to the #KICC2024 Abstract Submission deadline. This is your reminder to grab this golden opportunity and contribute to the #cancertreatment revolution in Africa! Submit now 🌟 bit.ly/3WTrEmB Abeid Athman (Omar). Ministry of Health National Cancer Institute of Kenya Kenya Hospices and Palliative Care Association

#KICC2024 Faculty Development Workshop in partnership with AORTIC Immerse yourself in a transformative journey of academic empowerment with our exclusive pre-conference workshop focused on faculty development. Tailored for #educators, #researchers & aspiring academic

Dr Kawango Agot, Rest in Power. A force for good in Kenya, a mentor of bright minds, a kind soul, and role model for many researchers. IDRO tribute: impact-rdo.org/tribute-to-kaw… crowdfunding site to support her family: gofund.me/1811c49f ⁦Harsha Thirumurthy⁩ ⁦University of Washington⁩ @avac

There is an increased risk of cancer among people with HIV globally. Check out this new publication by TAO that sheds light on the crucial intersection of oncology and HIV research, and offers new insights for clinical practice. WashU Medicine sciencedirect.com/science/articl…

Hot off the press from Kate Lurain Ramya Ramaswami TAO Elad Sharon Denise Whitby Important new data showing high and durable activity for anti-PD1 in HIV-KS! CITN12: Pembro in HIV-Associated Kaposi Sarcoma | JCO ascopubs.org/doi/10.1200/JC…

One hand cannot wash itself: excellent talk about the power of partnerships from Prof Elizabeth Bukusi ⁦University of Washington⁩ ⁦Implementation Science at the Univ of Washington⁩ ⁦@HIGH_IRI_WUSTL⁩

We're pleased to announce that we've updated our social media handles to reflect our new branding. Follow us at WashU Medicine Division of Oncology. Use the hashtag #WashUOncology to stay up-to-date on the latest news, research, and advancements from the WashU Medicine Division of Oncology

New #JITC position article and guidelines: Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee bit.ly/45IsF5g Nora Thomas Uldrick, MD Jyoti Bajpai

Check out the publication of a new manuscript titled, “Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee” on Journal for ImmunoTherapy of Cancer: jitc.bmj.com/content/13/6/e…